Sarissa goes after Alkermes, seeking three board seats at the Irish drugmaker
Activist investor Sarissa Capital Management is calling on Alkermes shareholders to vote for three of its proposed board members, saying the current board has limited oversight and is not accountable to shareholders.
In a letter published Tuesday morning, Sarissa requested that shareholders vote for three of its board candidates at Alkermes’ annual meeting later this month. Sarissa alleges that the current board “shunned our compromises” and would only meet with the investment fund twice a year, saying it’s “a matter of course” for companies to meet with major shareholders at least four times a year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.